retatrutide dopamine Do (reta) and survodutide increase levels? Weight loss drug retatrutide use
Description
Summary: Weight loss injections, particularly GLP-1 receptor agonists such as semaglutide and liraglutide, can cause dizziness as an uncommon side effect in up to 1 in 100 people
Early weight loss of 1-2kg was commonly reported
It was discovered during a high-throughput screening against 48,160 small molecules using a luciferase reporter assay in HEK293 cells expressing the rat GLP-1R (Chen et al., 2007)
10.2337/DB15-1141 8 ClarkeS
However, practical factors such as cost, patient adherence, and tolerability often make an add-on approach more feasible in real-world settings
Drugs, 75(10), 11411152
